Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
NEW YORK, July 10, 2012 (GLOBE NEWSWIRE) -- Pomerantz Haudek Grossman & Gross LLP is investigating claims on behalf of investors who purchased Centene Corp. ("Centene") securities. Such investors are...
-
NEW YORK, July 10, 2012 (GLOBE NEWSWIRE) -- Pomerantz Haudek Grossman & Gross LLP is investigating claims on behalf of investors who purchased DGSE Companies, Inc. ("DGSE") securities. Such investors...
-
NEW YORK, July 10, 2012 (GLOBE NEWSWIRE) -- Pomerantz Haudek Grossman & Gross LLP is investigating claims on behalf of investors who purchased Lone Pine Resources Inc. ("Lone Pine") securities. Such...
-
NEW YORK, July 10, 2012 (GLOBE NEWSWIRE) -- Pomerantz Haudek Grossman & Gross LLP is investigating claims on behalf of investors who purchased Tempur-Pedic International Inc. ("Tempur-Pedic")...
-
NEW YORK, July 10, 2012 (GLOBE NEWSWIRE) -- Pomerantz Haudek Grossman & Gross LLP is investigating claims on behalf of investors who purchased Assisted Living Concepts Inc. ("ALC") securities. Such...
-
NEW YORK, July 6, 2012 (GLOBE NEWSWIRE) -- Shareholders of Central European Distribution Corporation (Nasdaq:CEDC) or (the "Company") are reminded of the securities class action against CEDC and...
-
NEW YORK, July 6, 2012 (GLOBE NEWSWIRE) -- Shareholders of Tibet Pharmaceuticals, Inc. ("Tibet" or the "Company") (OTCBB:TBET) are reminded of the securities class action filed against Tibet and...
-
NEW YORK, July 6, 2012 (GLOBE NEWSWIRE) -- Shareholders of Facebook Inc. ("Facebook" or the "Company") (Nasdaq:FB) are reminded of the securities class action filed against Facebook and certain of its...
-
NEW YORK, July 5, 2012 (GLOBE NEWSWIRE) -- Pomerantz Haudek Grossman & Gross LLP has filed a federal securities class action 12-cv-05789-JAK-RZx in United States District Court, Central District...
-
NEW YORK, June 29, 2012 (GLOBE NEWSWIRE) -- Shareholders of ViroPharma Incorporated ("ViroPharma" or the "Company") (Nasdaq:VPHM) are reminded of the securities class action (2:12-cv-02714) filed...